|
Market Closed -
Other stock markets
|
After market 11:19:31 am | |||
| 884.8 DKK | -0.20% |
|
885.4 | +0.07% |
| 05:47pm | One dose of Novo Nordisk's Wegovy back in supply, FDA website shows | RE |
| 03:11pm | Big tech saves the day, again |  |
COPENHAGEN, April 8 (Reuters) - The Novo Nordisk Foundation has refiled an application to the U.S. Federal Trade Commission for approval of a $16.5 billion deal to buy Catalent, a spokesperson said on Monday. (Reporting by Jacob Gronholt-Pedersen, writing by Stine Jacobsen, editing by Anna Ringstrom)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 884.8 DKK | -0.20% | +1.09% | 566B | ||
| 56.28 USD | +0.63% | +0.22% | 10.12B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +26.74% | 566B | |
| +25.56% | 661B | |
| -6.84% | 352B | |
| +18.76% | 332B | |
| +3.15% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.54% | 145B | |
| -11.06% | 144B |
NOVO NORDISK A/S 
